On this page you can find an overview of the most important clinical studies on Hepa-Merz®, which prove the efficacy and tolerability of the drug.
Pivotal trial (key study): Hepa-Merz® Infusion concentrate
Hepa-Merz® infusion solution concentrate significantly reduces fasting and post-meal blood ammonia levels and leads to a significant improvement in HE symptoms. This makes Hepa-Merz® infusions an effective and well-tolerated treatment for chronic HE.